Components:
Method of action:
Treatment option:
Medically reviewed by Militian Inessa Mesropovna, PharmD. Last updated on 05.04.2022
Attention! Information on this page is intended only for medical professionals! Information is collected in open sources and may contain significant errors! Be careful and double-check all the information on this page!
Top 20 medicines with the same components:
Tixylix® Chesty Cough
Each 5ml contains Guaifenesin 50mg
Linctus
A clear, colourless or straw coloured solution
Expectorant for the symptomatic relief of acute productive (chesty) cough.
The linctus is for the lubrication and relief of the sore throat and hoarseness, which may be associated with the cough.
The following dose is taken 4 hourly. Do not exceed 6 doses in 24 hours.
Tixylix Chesty Cough is contra-indicated in children under 6 years of age.
6 - 10 years 5 to 10ml
Not to be used for more than 5 days without the advice of a doctor. Parents or carers should seek medical advice if the child's condition deteriorates during treatment.
Do not exceed the stated dose.
Keep out of the sight and reach of children.
Hypersensitivity to the active ingredients or to any of the excipients.
Not to be used in children under 6 years of age.
Consult a doctor before use if suffering from an acute asthma attack, a chronic cough or are asthmatic.
Stop use and consult a healthcare professional if the cough persists for longer than 5 days.
Stop use and consult a healthcare professional if the cough is accompanied by a fever, rash or persistent headache or is recurrent.
If symptoms persist, consult a doctor.
Keep out of the sight and reach of children.
Do not exceed the stated dose.
Do not take with any other cough and cold medicine, including cough suppressants.
None.
The following side effects may be associated with the use of guaifenesin:
Gastro-intestinal Disorders: nausea, vomiting
Immune System Disorders: hypersensitivity reactions
Symptoms of very large overdosage are nausea and vomiting. Guaifenesin is, however, rapidly metabolised and excreted in the urine. Patients should be kept under observation and treated symptomatically.
Guaifenesin is reported to reduce the viscosity of tenacious sputum and is used as an expectorant.
Guaifenesin is readily absorbed from the gastrointestinal tract. It is readily metabolised and excreted in the urine. It has a plasma half life of 1 hour.
None.
Sodium benzoate
Sodium saccharin
Glycerol
Sorbital solution (70%) (Non-cryst)
Citric acid monohydrate or anhydrous citric acid
Blackcurrant flavour DA13624
Vanilla flavour NN21166
Acesulfame Potassium
Hydroxyethylcellulose
Purified water
None.
36 months.
Store below 25°C.
| Container: | Amber glass bottles |
| Closure: | Wadded, aluminium roll-on pilfer-proof closure (ROPP) or Wadded, polypropylene or polypropylene/HDPE child resistant tamper evident closure |
| Wad: | PVdC-coated. Board or EPE |
Each bottle contains 100 ml or 150ml.
Keep all medicines out of the reach of children.
Novartis Consumer Health UK Limited
Park View,
Riverside Way,
Watchmoor Park,
Camberley,
Surrey,
GU15 3YL
Trading as: Novartis Consumer Health
PL 00030/0082
Granted: 1 August 1997
25 July 2013
